These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 6124396)
1. New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation. Walle T; Oatis JE; Walle UK; Knapp DR Drug Metab Dispos; 1982; 10(2):122-7. PubMed ID: 6124396 [TBL] [Abstract][Full Text] [Related]
2. Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro. Talaat RE; Nelson WL Drug Metab Dispos; 1988; 16(2):207-11. PubMed ID: 2898334 [TBL] [Abstract][Full Text] [Related]
3. Regioisomeric aromatic dihydroxylation of propranolol. Synthesis and identification of 4,6- and 4,8-dihydroxypropranolol as metabolites in the rat and in man. Talaat RE; Nelson WL Drug Metab Dispos; 1988; 16(2):212-6. PubMed ID: 2898335 [TBL] [Abstract][Full Text] [Related]
4. Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques. Bargar EM; Walle UK; Bai SA; Walle T Drug Metab Dispos; 1983; 11(3):266-72. PubMed ID: 6135586 [TBL] [Abstract][Full Text] [Related]
5. Isomeric ring hydroxylated metabolites of propranolol in rats, man and dogs. Walle T; Morrison JI; Tindell GL Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):1-10. PubMed ID: 4438819 [No Abstract] [Full Text] [Related]
6. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction. Talaat RE; Nelson WL Drug Metab Dispos; 1986; 14(2):202-7. PubMed ID: 2870895 [TBL] [Abstract][Full Text] [Related]
7. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates. Walle T; Wilson MJ; Walle UK; Bai SA Drug Metab Dispos; 1983; 11(6):544-9. PubMed ID: 6140137 [TBL] [Abstract][Full Text] [Related]
8. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects. Nelson WL; Bartels MJ Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562 [TBL] [Abstract][Full Text] [Related]
9. Disposition of [14C]velnacrine maleate in rats, dogs, and humans. Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382 [TBL] [Abstract][Full Text] [Related]
10. Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol. Gustavson LM; Nelson WL Drug Metab Dispos; 1988; 16(2):217-21. PubMed ID: 2898336 [TBL] [Abstract][Full Text] [Related]
11. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity. von Bahr C; Hermansson J; Lind M J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564 [TBL] [Abstract][Full Text] [Related]
12. Chemical aspects of propranolol metabolism. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)propane-1,2-diol as a metabolite of propranolol in the dog, in man and in the rat liver 9000g supernatant fraction. Gupte SM; Bartels MJ; Kerr BM; Laganiere S; Silber BM; Nelson WL Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):235-44. PubMed ID: 6658188 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog. Christ DD; Walle UK; Oatis JE; Walle T Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766 [TBL] [Abstract][Full Text] [Related]
14. Beta- to omega-hydroxylation of the esophageal carcinogen methyl-n-amylnitrosamine by the rat esophagus and related tissues. Mirvish SS; Wang MY; Smith JW; Deshpande AD; Makary MH; Issenberg P Cancer Res; 1985 Feb; 45(2):577-83. PubMed ID: 3967233 [TBL] [Abstract][Full Text] [Related]
15. The metabolism of roxatidine acetate hydrochloride. Liberation of deuterium from the piperidine ring during hydroxylation. Honma S; Iwamura S; Kobayashi R; Kawabe Y; Shibata K Drug Metab Dispos; 1987; 15(4):551-9. PubMed ID: 2888630 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man. Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841 [TBL] [Abstract][Full Text] [Related]
17. Isolation, purification, and structure identification of glucuronic acid conjugates of propranolol and alprenolol and their ring-hydroxylated metabolites. Bai SA; Walle T Drug Metab Dispos; 1984; 12(6):749-54. PubMed ID: 6150825 [TBL] [Abstract][Full Text] [Related]
18. Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance. Dahms M; Lotz R; Lang W; Renner U; Bayer E; Spahn-Langguth H Drug Metab Dispos; 1997 Apr; 25(4):442-52. PubMed ID: 9107544 [TBL] [Abstract][Full Text] [Related]
19. Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog. Butler TC; Dudley KH; Johnson D; Roberts SB J Pharmacol Exp Ther; 1976 Oct; 199(1):82-92. PubMed ID: 978486 [TBL] [Abstract][Full Text] [Related]
20. Identification of major sulfate conjugates in the metabolism of propranolol in dog and man. Walle T; Walle UK; Knapp DR; Conradi EC; Bargar EM Drug Metab Dispos; 1983; 11(4):344-9. PubMed ID: 6137341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]